Avoro Capital Advisors LLC: 13F holdings
CIK 16333132026Q2
| Positions | 26 |
|---|
| Reported value | $11.1bn |
|---|
| Filed | 2026-08-14 |
|---|
Change since last quarter
| Positions | 26 (-4 vs prior quarter) |
|---|
| Reported value | $11.1bn (+9.6%) |
|---|
Top 10 holdings
| Security | Shares | Value | Weight |
|---|
| UTHR UNITED THERAPEUTICS CORP | 2,777,777 | $1.5bn | 13.5% |
| ASCENDIS PHARMA | 5,111,111 | $1.4bn | 12.2% |
| KRYS KRYSTAL BIOTECH INC | 2,888,888 | $1.1bn | 9.6% |
| MDGL MADRIGAL PHARMACEUTICALS INC | 1,833,333 | $984.4m | 8.8% |
| ARGX ARGENX SE | 1,000,000 | $927.8m | 8.3% |
| ARWR ARROWHEAD PHARMACEUTICALS INC | 11,355,555 | $925.6m | 8.3% |
| KYMR KYMERA THERAPEUTICS INC | 7,474,747 | $857.1m | 7.7% |
| RVMD REVOLUTION MEDICINES INC | 2,297,000 | $430.2m | 3.9% |
| CYTK CYTOKINETICS INC | 4,999,999 | $425.9m | 3.8% |
| CELC CELCUITY INC | 3,400,000 | $355.7m | 3.2% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="1633313")
Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.
Get a free API keySee history bundlesDownload free samples